PureHealth - Public Comps and Valuation Multiples

PureHealth Overview

About PureHealth

Pure Health Holding PJSC is an integrated healthcare company in the United Arab Emirates with a cross-category ecosystem covering hospitals, clinics, diagnostics, insurance, pharmacies, research, health tech, and procurement along with an international footprint in the United States and the United Kingdom. The company's reportable segments are; Hospital management services, Laboratory management services, Procurement and supply of medical-related products, Hospitalisation and other related services, Health insurance services, and Services and others. Key revenue is derived from its Hospitalisation and other related services segment through which it provides general healthcare operations including hospitalization, clinical, isolation/quarantine, vaccinations, and other services.

Founded

2021

HQ

Employees

56K+

Website

purehealth.ae

Sectors

Hospitals & Clinics

Financials

LTM Revenue $7.3B

LTM EBITDA $1.2B

EV

$10.6B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

PureHealth Financials

PureHealth has a last 12-month revenue of $7.3B and a last 12-month EBITDA of $1.2B.

In the most recent fiscal year, PureHealth achieved revenue of $7.0B and an EBITDA of $1.1B.

PureHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX

See PureHealth valuation multiples based on analyst estimates

PureHealth P&L

	FY 2022	FY 2023	FY 2024	LTM	NTM
Revenue	$3.3B	$4.5B	$7.0B	$7.3B	XXX
Gross Profit	$1.3B	$696M	$1.8B	XXX	XXX
Gross Margin	38%	16%	26%	XXX	XXX
EBITDA	$1.3B	$671M	$1.1B	$1.2B	XXX
EBITDA Margin	38%	15%	16%	17%	XXX
Net Profit	$1.0B	$263M	$466M	XXX	XXX
Net Margin	30%	6%	7%	XXX	XXX
Net Debt	n/a	n/a	n/a	XXX	XXX

Financial data powered by Morningstar, Inc.

PureHealth Stock Performance

As of February 21, 2025, PureHealth's stock price is AED 3 (or $1).

PureHealth has current market cap of AED 35.6B (or $9.7B), and EV of AED 38.9B (or $10.6B).

See PureHealth trading valuation data

PureHealth Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$10.6B	$9.7B	XXX	XXX	XXX	XXX	$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

PureHealth Valuation Multiples

As of February 21, 2025, PureHealth has market cap of $9.7B and EV of $10.6B.

PureHealth's trades at 1.5x LTM EV/Revenue multiple, and 8.7x LTM EBITDA.

Analysts estimate PureHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for PureHealth and 10K+ public comps

PureHealth Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$10.6B	XXX	XXX	XXX
EV/Revenue	1.5x	XXX	XXX	XXX
EV/EBITDA	9.3x	XXX	XXX	XXX
P/E	20.8x	XXX	XXX	XXX
P/E/Growth	0.6x	XXX	XXX	XXX
EV/FCF	12.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get PureHealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

PureHealth Valuation Multiples

PureHealth's NTM/LTM revenue growth is 13%

PureHealth's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $23K for the same period.

Over next 12 months, PureHealth's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate PureHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for PureHealth and other 10K+ public comps

PureHealth Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	58%	XXX	XXX	XXX	XXX
EBITDA Margin	16%	XXX	XXX	XXX	XXX
EBITDA Growth	69%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	29%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.1M	XXX	XXX	XXX	XXX
Opex per Employee	$23K	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	0%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	5%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	18%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Medical Devices

Consumer SaaS

Streaming Platforms

AdTech Software

Climate Tech

GRC Software

Developer Tools

Explore Valuation Multiples by Industry